Letrozole 2.5mg: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Letrozole 2.5mg

• Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism
  NCT06041204 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 40 Years · Sex: Female · 1 location
• Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
  NCT07285382 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 112 locations
• GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
  NCT05316935 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · 2 locations
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
  NCT06379113 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · 2 locations
• Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
  NCT06953882 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Letrozole 2.5mg?

6 recruiting trials across 14 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.